|
LOC728723 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.107980E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.453970E-02 |
| Normal-vs-Stage2 |
1.189660E-02 |
| Normal-vs-Stage3 |
7.672600E-01 |
| Normal-vs-Stage4 |
3.957300E-03 |
| Stage1-vs-Stage2 |
5.639000E-01 |
| Stage1-vs-Stage3 |
2.110400E-01 |
| Stage1-vs-Stage4 |
1.333200E-01 |
| Stage2-vs-Stage3 |
1.850160E-01 |
| Stage2-vs-Stage4 |
3.285800E-01 |
| Stage3-vs-Stage4 |
5.758200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.167600E-02 |
| Normal-vs-AfricanAmerican |
1.740090E-03 |
| Normal-vs-Asian |
9.991400E-01 |
| Caucasian-vs-AfricanAmerican |
6.639500E-02 |
| Caucasian-vs-Asian |
4.533800E-01 |
| AfricanAmerican-vs-Asian |
4.218600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.561800E-03 |
| Normal-vs-Female |
5.558000E-01 |
| Male-vs-Female |
3.472300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.438400E-01 |
| Normal-vs-Extreme_Weight |
8.571200E-04 |
| Normal-vs-Obese |
2.070200E-01 |
| Normal-vs-Extreme_Obese |
1.981570E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.451570E-01 |
| Normal_Weight-vs-Obese |
7.685400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.691000E-01 |
| Extreme_Weight-vs-Obese |
1.792380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.230000E-01 |
| Obese-vs-Extreme_Obese |
8.987400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.840800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.094200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.779840E-02 |
| Normal-vs-Age(81-100Yrs) |
2.499000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.710100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.972000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.557400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.198400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.342000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.178600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.57039999999898E-05 |
| Normal-VS-Type2 PRCC |
4.855800E-01 |
| Normal-VS-KIRP CIMP |
1.318410E-03 |
| Normal-VS-Unclassified PRCC |
7.979800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.386000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.978500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.195640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.660500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.130400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.107900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.188000E-01 |
| Normal-vs-N1 |
2.661300E-03 |
| Normal-vs-N2 |
3.490000E-01 |
| N0-vs-N1 |
7.742400E-02 |
| N0-vs-N2 |
7.548600E-01 |
| N1-vs-N2 |
5.943800E-01 |
|
|
